ASPIVIX SA

At ASPIVIX, a Swiss MedTech company, we aim at serving the gynaecology market with a new generation of pain-free single use surgical instrument, to replace the current middle-age painful cervical forceps affecting more than 75 million women every year in routine interventions requiring access to the uterine cavity.
Aspivix innovates women's care with new surgical instrument for gentler and more modern gynaecological procedures.